7.9(top 2%)
impact factor
2.5K(top 10%)
178.8K(top 2%)
201(top 1%)
8.0(top 2%)
extended IF
all documents
doc citations
319(top 1%)

Top Articles

1Signaling to NF-κB by Toll-like receptorsTrends in Molecular Medicine20071,932
2MicroRNAs in cancer: biomarkers, functions and therapyTrends in Molecular Medicine20141,732
3Nrf2–Keap1 defines a physiologically important stress response mechanismTrends in Molecular Medicine20041,529
4DNA damage-induced cell death by apoptosisTrends in Molecular Medicine20061,272
5The ‘cytokine profile’: a code for sepsisTrends in Molecular Medicine20051,066
6Inflammatory networks during cellular senescence: causes and consequencesTrends in Molecular Medicine20101,052
7Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptideTrends in Molecular Medicine20011,044
8Mesenchymal stem cells: building blocks for molecular medicine in the 21st centuryTrends in Molecular Medicine20011,020
9MITF: master regulator of melanocyte development and melanoma oncogeneTrends in Molecular Medicine2006993
10RANKL–RANK signaling in osteoclastogenesis and bone diseaseTrends in Molecular Medicine2006970
11HIF-1 and tumor progression: pathophysiology and therapeuticsTrends in Molecular Medicine2002915
12CD39 and CD73 in immunity and inflammationTrends in Molecular Medicine2013914
13Microbiota and neurodevelopmental windows: implications for brain disordersTrends in Molecular Medicine2014852
14Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiologyTrends in Molecular Medicine2001830
15Protein carbonylation in human diseasesTrends in Molecular Medicine2003813
16Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's diseaseTrends in Molecular Medicine2008799
17Sialic acids in human health and diseaseTrends in Molecular Medicine2008797
18Tau phosphorylation: the therapeutic challenge for neurodegenerative diseaseTrends in Molecular Medicine2009778
19Carbapenem resistance in Enterobacteriaceae: here is the storm!Trends in Molecular Medicine2012777
20The infant microbiome development: mom mattersTrends in Molecular Medicine2015756
21The tripartite synapse: roles for gliotransmission in health and diseaseTrends in Molecular Medicine2007717
22MicroRNA expression and function in cancerTrends in Molecular Medicine2006699
23Protein S-nitrosylation in health and disease: a current perspectiveTrends in Molecular Medicine2009670
24The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancerTrends in Molecular Medicine2008632
25Antibiotic-Induced Changes in the Intestinal Microbiota and DiseaseTrends in Molecular Medicine2016630
26Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathwayTrends in Molecular Medicine2015628
27Hsp90 inhibitors as novel cancer chemotherapeutic agentsTrends in Molecular Medicine2002618
28Natural regulatory T cells: mechanisms of suppressionTrends in Molecular Medicine2007616
29Circulating tumour cells in cancer patients: challenges and perspectivesTrends in Molecular Medicine2010616
30Chemokines and chemokine receptors: new insights into cancer-related inflammationTrends in Molecular Medicine2010603
31Quantification using real-time PCR technology: applications and limitationsTrends in Molecular Medicine2002602
32Epigenetic mechanisms of perinatal programming of hypothalamic-pituitary-adrenal function and healthTrends in Molecular Medicine2007594
33MUC1: a multifaceted oncoprotein with a key role in cancer progressionTrends in Molecular Medicine2014592
34The role of pyocyanin in Pseudomonas aeruginosa infectionTrends in Molecular Medicine2004591
35Why have clinical trials in sepsis failed?Trends in Molecular Medicine2014588
36Cell-penetrating peptides: breaking through to the other sideTrends in Molecular Medicine2012586
37The role of selectins in inflammation and diseaseTrends in Molecular Medicine2003581
38Cancer nanomedicine: from targeted delivery to combination therapyTrends in Molecular Medicine2015578
39Disease Modeling in Stem Cell-Derived 3D Organoid SystemsTrends in Molecular Medicine2017575
40Endoplasmic reticulum stress, obesity and diabetesTrends in Molecular Medicine2012559
41Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapyTrends in Molecular Medicine2001558
42Osteoclast-derived activity in the coupling of bone formation to resorptionTrends in Molecular Medicine2005550
43Mesenchymal stem cell therapy: Two steps forward, one step backTrends in Molecular Medicine2010545
44Clinical application of pharmacogeneticsTrends in Molecular Medicine2001544
45NF-κB as a therapeutic target in cancerTrends in Molecular Medicine2002544
46Estrogen synthesis and signaling pathways during aging: from periphery to brainTrends in Molecular Medicine2013542
47let-7 microRNAs in development, stem cells and cancerTrends in Molecular Medicine2008539
48Pleiotropic effects of statin therapy: molecular mechanisms and clinical resultsTrends in Molecular Medicine2008522
49The Dual Roles of NRF2 in CancerTrends in Molecular Medicine2016508
50S-nitrosylation in health and diseaseTrends in Molecular Medicine2003503